Congress Fails to Pass PBM Reform
Congress failed to pass legislation reforming pharmacy benefit managers (PBMs), despite bipartisan efforts, leaving in place an industry criticized for opaque practices and potential conflicts of interest. The legislation aimed to increase transparency and change the compensation structure of PBMs, ...
Congress Fails to Pass PBM Reform
Congress failed to pass legislation reforming pharmacy benefit managers (PBMs), despite bipartisan efforts, leaving in place an industry criticized for opaque practices and potential conflicts of interest. The legislation aimed to increase transparency and change the compensation structure of PBMs, ...
Progress
40% Bias Score
France Approves Wegovy Reimbursement for Severely Obese Adults
France's Haute Autorité de Santé (HAS) approved Wegovy reimbursement for severely obese adults (BMI ≥35 kg/m²), following new data demonstrating reduced cardiovascular risks and approximately 17% weight loss; the drug, costing €274–€365 monthly, necessitates combined use with diet and exercise.
France Approves Wegovy Reimbursement for Severely Obese Adults
France's Haute Autorité de Santé (HAS) approved Wegovy reimbursement for severely obese adults (BMI ≥35 kg/m²), following new data demonstrating reduced cardiovascular risks and approximately 17% weight loss; the drug, costing €274–€365 monthly, necessitates combined use with diet and exercise.
Progress
36% Bias Score
Spain to Restructure Pharmaceutical Co-payments, Expand Prescribing Rights
Spain's Ministry of Health proposes a new pharmaceutical co-payment law, creating six income brackets, capping monthly expenses for low earners, expanding prescription rights for nurses and physiotherapists, prioritizing generic drugs, and granting the AEMPS more power over drug supply.
Spain to Restructure Pharmaceutical Co-payments, Expand Prescribing Rights
Spain's Ministry of Health proposes a new pharmaceutical co-payment law, creating six income brackets, capping monthly expenses for low earners, expanding prescription rights for nurses and physiotherapists, prioritizing generic drugs, and granting the AEMPS more power over drug supply.
Progress
36% Bias Score